| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.283 | 75.609 | 118.454 | 492.878 | 462.299 | 379.395 | 490.415 | 428.072 | 496.676 | 382.534 |
| Total Income - EUR | 47.325 | 76.431 | 119.321 | 591.568 | 489.644 | 484.923 | 519.604 | 461.608 | 497.237 | 397.950 |
| Total Expenses - EUR | 42.335 | 72.135 | 103.908 | 563.557 | 475.666 | 379.094 | 483.436 | 446.771 | 472.030 | 364.886 |
| Gross Profit/Loss - EUR | 4.989 | 4.296 | 15.413 | 28.012 | 13.978 | 105.828 | 36.168 | 14.837 | 25.208 | 33.064 |
| Net Profit/Loss - EUR | 3.570 | 2.767 | 13.771 | 23.298 | 9.349 | 101.421 | 31.398 | 11.048 | 20.233 | 22.869 |
| Employees | 1 | 1 | 2 | 4 | 5 | 3 | 3 | 4 | 3 | 2 |
Check the financial reports for the company - Necemis Fitofarma 2015 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 96.812 | 162.529 | 158.367 | 203.554 | 245.467 | 244.723 | 244.470 |
| Current Assets | 39.771 | 9.088 | 66.609 | 69.749 | 100.150 | 63.656 | 121.052 | 175.479 | 135.383 | 94.245 |
| Inventories | 11.792 | 8.667 | 60.602 | 48.750 | 71.248 | 55.744 | 49.606 | 111.430 | 105.380 | 66.415 |
| Receivables | 0 | 163 | 3.808 | 14.012 | 24.326 | 4.065 | 52.422 | 63.118 | 19.758 | 18.172 |
| Cash | 27.980 | 257 | 2.199 | 6.987 | 4.576 | 3.846 | 19.024 | 931 | 10.245 | 9.658 |
| Shareholders Funds | 3.660 | 3.050 | 14.055 | 37.095 | 45.726 | 146.280 | 174.435 | 186.023 | 205.692 | 222.159 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 36.112 | 6.038 | 52.554 | 129.466 | 216.953 | 75.743 | 150.171 | 234.923 | 174.413 | 116.556 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Necemis Fitofarma 2015 Srl